Company

Revolution Medicines Inc RVMD

Tracked across 6 disclosed holders on Protégé.

6 tracked investors, latest 13F quarter ending 30 Jun 2026 · latest filing 14 Aug 2026

Held by these investors

All of 6 tracked investors by weight in their own portfolio. Source: each investor's latest SEC Form 13F-HR; quarter end and filing date per row.
InvestorWeight in portfolioValue (13F)Quarter endingFiled
Farallon Capital Management15.0%$2.5B2026-06-302026-08-14
Baker Brothers Investments10.8%$2.1B2026-06-302026-08-14
Stanley Druckenmiller1.7%$74.8M2026-06-302026-08-14
Boothbay Fund Management1.6%$87.2M2026-06-302026-08-14
Woodline Partners1.2%$375.1M2026-06-302026-08-14
Holocene Advisors0.6%$254.6M2026-06-302026-08-14

Sources: SEC EDGAR (Form 13F-HR and Form 4) and the official House and Senate STOCK Act disclosures. Filings are quarterly or delayed, so current holdings may differ. Weights are each holder's own portfolio share, not a share of the company.

Open the companies explorer for RVMD